Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Taxes × Clear all

Phase

Status

Withdrawn 4 Completed 4 Recruiting 3 Active not recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Advanced Pancreatic Cancer 3 Esophageal Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Staging IV NSCLC 1 Stage III Lung Non-Small Cell Cancer AJCC v7 1 Squamous Cell Carcinoma of Lung 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Ovarian gynandroblastoma 1 Obesity 1 Neurotoxicity Syndromes 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 HER2+ Breast Cancer 1 Granulosa cell tumor of the ovary 1 Gallbladder Neoplasms 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04652206 2021-12-29

PANTAX-Ib

Scandion Oncology A/S

Phase 1/2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡